Abstract
Two kinds of arginine deiminase (AD, EC 3.5.3.6) were purified from cell extracts of Mycoplasma arginini (a‐AD) and Mycoplasma hominis (h‐AD), and their enzymic properties and anti‐tumor activities were compared. The a‐AD enzyme strongly inhibited the growth of mouse hepatoma cell line MH134 in vitro, and its concentration required for 50% growth inhibition (IC50) was estimated to be about 10 ng/ml. The IC50 value of h‐AD against the same cell line was estimated to be ahout 100 ng/ml, due to its low enzyme activity under the physiological pH condition, i.e., pH 7.4. These results show that the reaction pH profile of the a‐AD was superior to that of the h‐AD as an anti‐tumor enzyme. Moreover, the effects of l‐arginine metabolism‐related substances on the anti‐tumor activity of the a‐AD were examined to study the growth‐inhibitory mechanism of this enzyme. The addition of 2 or 4 mMl‐arginine restored, in a dose‐dependent manner, the growth of mouse MH134 hepatoma and Meth A fibrosarcoma cell lines that had been inhibited by 20 ng/ml of the a‐AD. The addition of 2 or 4 mMl‐ornithine, which is biosynthesized from l‐arginine in the urea cycle and is the starting material in the polyamine‐biosynthesis pathway, also partially restored it in a dose‐dependent manner. These results indicate that the tumor cell growth inhibition caused by a‐AD originates from the depletion of the essential nutrient l‐arginine, and that the resulting block of the polyamine‐biosynthesis pathway is involved in part in the inhibitory mechanism.
Keywords: Arginine deiminase, Inhibitory mechanism, Tumor cell growth, Mycoplasma
Full Text
The Full Text of this article is available as a PDF (412.8 KB).
REFERENCES
- 1. ) Broom , J. D.Evidence that the l‐asparaginase activity of guinea pig serum is responsible for its antilymphoma effects . Nature , 191 , 1114 – 1115 ( 1961. ). [Google Scholar]
- 2. ) Mashburn , L. T. and Wriston , J. C.Tumor inhibitory effect of l‐asparaginase from Escherichia coli . Arch. Biochem. Biophys. , 105 , 450 – 452 ( 1964. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Burton , A. F.The effect of arginase on tumor cells . Proc. Am. Assoc. Cancer Res. , 10 , 12 ( 1969. ). [Google Scholar]
- 4. ) Storr , J. M. and Burton , A. F.The effects of arginine deficiency on lymphoma cells . Br. J. Cancer , 30 , 50 – 59 ( 1974. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. ) Weider , J. K. , Palczuk , N. C. , van Es , T. and Davis , F. F.Some properties of polyethylene glycol: phenylalanine ammonia‐lyase adducts . J. Biol. Chem. , 254 , 12579 – 12587 ( 1979. ). [PubMed] [Google Scholar]
- 6. ) Yoshimoto , T. , Chao , S. G. , Saito , Y. , Imamura , I. , Wada , H. and Inada , Y.Chemical modification of tryptophanase from E. coli with polyethylene glycol to reduce its immuno‐reactivity towards anti‐tryptophanase antibodies . Enzyme , 36 , 261 – 265 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Kidd , J. Q.Asparaginase and cancer — yesterday and today — recent results . Cancer Res. , 33 , 3 – 14 ( 1973. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Cunin , R. , Glansdorff , N. , Pierard , A. and Stalon , V.Biosynthesis and metabolism of arginine in bacteria . Microbiol. Rev. , 50 , 314 – 352 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. ) Marquis , R. E. , Bender , G. R. , Murray , D. R. and Wong , A.Arginine deiminase system and bacterial adaptation to acid environments . Appl. Environ. Microbiol. , 53 , 198 – 200 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Schimke , R. T. , Berlin , C. M. , Sweeney , E. W. and Carroll , W. R.The generation of energy by the arginine dihydrolase pathway in Mycoplasma hominis 07 . J. Biol. Chem. , 241 , 2228 – 2236 ( 1966. ). [PubMed] [Google Scholar]
- 11. ) Miyazaki , K. , Takaku , H. , Umeda , M. , Fujita , T. , Huang , W. , Kimura , T. , Yamashita , J. and Horio , T.Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of a Mycoplasma‐infected cell line . Cancer Res. , 50 , 4522 – 4527 ( 1990. ). [PubMed] [Google Scholar]
- 12. ) Takaku , H. , Takase , M. , Abe , S. , Hayashi , H. and Miyazaki , K.In vivo anti‐tumor activity of arginine deiminase purified from Mycoplasma arginini . Int. J. Cancer , 51 , 244 – 249 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Takaku , H. , Misawa , S. , Hayashi , H. and Miyazaki , M.Chemical modification by polyethylene glycol of the anti‐tumor enzyme arginine deiminase from Mycoplasma arginini . Jpn. J. Cancer Res. , 84 , 1195 – 1200 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. ) Misawa , S. , Aoshima , M. , Takaku , H. , Matsumoto , M. and Hayashi , H.High‐level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti‐tumor enzyme . J. Biotechnol. , 36 , 145 – 155 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Lin , J. S.Arginine deiminase of Mycoplasma hominis: cytoplasmic and membrane‐associated forms . J. Gen. Microbiol. , 132 , 1467 – 1474 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Oginski , E. L.Isolation and determination of arginine and citrulline . Methods Enzymol. , 3 , 639 – 643 ( 1957. ). [Google Scholar]
- 17. ) Laemmli , U. K.Cleavage of structural proteins during assembly of the head of bacteriophage T4 . Nature , 227 , 680 – 685 ( 1970. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Ohno , T. , Ando , O. , Sugimura , K. , Taniai , M. , Suzuki , M. , Fukuda , S. , Nagase , Y. , Yamamoto , K. and Azuma , I.Cloning and nucleotide sequence of the gene encoding arginine deiminase of Mycoplasma arginini . Infect. Immun. , 58 , 3788 – 3795 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. ) Harasawa , R. , Koshimizu , K. , Kitagawa , M. , Asada , K. and Kato , I.Nucleotide sequence of the arginine deiminase gene of Mycoplasma hominis . Microbiol. Immunol. , 36 , 661 – 665 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Beruter , J. and Colombo , J. P.Purification and properties of arginase from human liver and erythrocytes . Biochem. J. , 175 , 449 – 454 ( 1978. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. ) Savoca , K. V. , Davis , F. F. , van Es , T. , McCoy , J. R. and Palczuk , N. C.Cancer therapy with chemically modified enzymes. II. The therapeutic effectiveness of arginase, and arginase modified by the covalent attachment of polyethylene glycol, on the Taper liver tumor and the L5178Y murine leukemia . Cancer Biochem. Biophys. , 7 , 261 – 268 ( 1984. ). [PubMed] [Google Scholar]
- 22. ) Wriston , J. C. and Yellin , T. O.Factors that may play a role in determining the effectiveness of asparaginase in vivo . Adv. Enzymol. , 39 , 226 – 230 ( 1973. ). [Google Scholar]
- 23. ) Pegg , A. E.Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy . Cancer Res. , 48 , 759 – 774 ( 1988. ). [PubMed] [Google Scholar]
- 24. ) Gonzalez , G. G. and Byus , C. V.Effect of dietary arginine restriction upon ornithine and polyamine metabolism during two‐stage epidermal carcinogenesis in the mouse . Cancer Res. , 51 , 2932 – 2939 ( 1991. ). [PubMed] [Google Scholar]
- 25. ) Pera , P. J. , Kramer , D. L. , Sufrin , J. R. and Porter , C. W.Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines . Cancer Res. , 46 , 1148 – 1154 ( 1986. ). [PubMed] [Google Scholar]
- 26. ) Takigawa , M. , Enomoto , M. , Nishida , Y. , Pan , H. O. , Kinoshita , A. and Suzuki , F.Tumor angiogenesis and polyamines: alpha‐difluoromethylomithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma‐induced angiogenesis in vivo and the proliferation of vascular endothelial cells in vitro . Cancer Res. , 50 , 4131 – 4138 ( 1990. ). [PubMed] [Google Scholar]